Cureus · 2025
Evaluating the Anxiolytic Efficacy of Oral Alprazolam in Modulating Vital Parameters During Minor Oral Surgical Procedures: A Quasi-experimental Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mulla Misbah F, Pagare Vaishali, Changule Govind R, Doiphode Amol, Mulla Mazharkhan, Jawarker Rohie, Kaul Deepak, Gupta Seema
Аннотация
INTRODUCTION: Dental anxiety is a prevalent issue among patients undergoing minor oral surgical procedures such as extractions, biopsies, and implant placement. This study aimed to evaluate the impact of oral alprazolam as a premedicative anxiolytic agent on vital parameters, including pulse rate (PR), systolic and diastolic blood pressure (SBP and DBP, respectively), respiratory rate (RR), and oxygen saturation (SpO2), in patients undergoing minor oral surgeries.
MATERIALS AND METHODS: A quasi-experimental study was conducted on patients aged 18-45 years who required minor oral surgical procedures under local anesthesia (LA) and were divided into two groups based on the Dental Anxiety Scale (DAS) scores. Group 1 (anxious; DAS score > 11) received 0.25 mg oral alprazolam 30 minutes pre-operatively, while Group 2 (non-anxious/mildly anxious; DAS score < 10) underwent surgery without alprazolam. Vital parameters were recorded at three intervals: preoperatively (T0), intraoperatively (15 minutes after starting surgery; T1), and postoperatively (30 minutes after surgery; T2). Statistical analyses included independent t-tests and logistic regression analyses to evaluate differences and associations.
RESULTS: A significant reduction in PR, RR, and SBP was observed in Group 1 across all intervals, compared to Group 2, indicating the effectiveness of alprazolam in stabilizing physiological responses. Postoperative SpO₂ levels remained unaffected in both groups, ensuring patient safety. Logistic regression analysis revealed that elevated preoperative PR, SBP, and RR were significant predictors of anxiety, highlighting their role in identifying candidates for anxiolytic premedication.
CONCLUSION: Premedication with 0.25 mg oral alprazolam effectively alleviated anxiety and stabilized vital parameters during minor oral surgeries, thereby enhancing patient comfort and procedural efficacy. These findings emphasize the importance of incorporating anxiolytic strategies into dental practice to optimize patient care and surgical outcomes. Future studies should explore different doses and broader populations to refine the anxiolytic interventions.
MATERIALS AND METHODS: A quasi-experimental study was conducted on patients aged 18-45 years who required minor oral surgical procedures under local anesthesia (LA) and were divided into two groups based on the Dental Anxiety Scale (DAS) scores. Group 1 (anxious; DAS score > 11) received 0.25 mg oral alprazolam 30 minutes pre-operatively, while Group 2 (non-anxious/mildly anxious; DAS score < 10) underwent surgery without alprazolam. Vital parameters were recorded at three intervals: preoperatively (T0), intraoperatively (15 minutes after starting surgery; T1), and postoperatively (30 minutes after surgery; T2). Statistical analyses included independent t-tests and logistic regression analyses to evaluate differences and associations.
RESULTS: A significant reduction in PR, RR, and SBP was observed in Group 1 across all intervals, compared to Group 2, indicating the effectiveness of alprazolam in stabilizing physiological responses. Postoperative SpO₂ levels remained unaffected in both groups, ensuring patient safety. Logistic regression analysis revealed that elevated preoperative PR, SBP, and RR were significant predictors of anxiety, highlighting their role in identifying candidates for anxiolytic premedication.
CONCLUSION: Premedication with 0.25 mg oral alprazolam effectively alleviated anxiety and stabilized vital parameters during minor oral surgeries, thereby enhancing patient comfort and procedural efficacy. These findings emphasize the importance of incorporating anxiolytic strategies into dental practice to optimize patient care and surgical outcomes. Future studies should explore different doses and broader populations to refine the anxiolytic interventions.